President Donald Trump publicly commended Health and Human Services Secretary Robert F. Kennedy Jr. for his performance during a contentious Senate hearing, even as some Republican lawmakers expressed growing concerns over his controversial leadership at HHS. This support comes amid a backdrop of internal party dissent and public health policy upheavals.
On September 4, 2025, RFK Jr. faced a blistering three-hour hearing before the Senate Finance Committee, where he was grilled by senators from both parties over his recent decisions, including the abrupt firing of CDC Director Susan Monarez and new restrictions on COVID-19 vaccine access. Democrats and Republicans alike challenged his approach, with several calling for his resignation due to fears that his policies could undermine public health and vaccine confidence.
Trump, however, remained steadfast in his support. At a White House event, he praised Kennedy, saying, “I heard he did very well today,” and appreciated that Kennedy is “different” in his medical and vaccine views. Trump aides and allies echoed this sentiment, viewing Kennedy’s combative testimony as a display of loyalty and strength that aligns with the president’s agenda.
Kennedy’s tenure has been marked by significant turmoil, including mass firings at health agencies and a reassessment of vaccine policies. His decision to oust Monarez and replace the CDC’s vaccine advisory panel with skeptics has alarmed many in the medical community, leading to bipartisan criticism. Senators like Bill Cassidy and John Barrasso, both Republicans and physicians, voiced deep concerns about the potential risks to vaccine access and public health.
Despite the criticism, Kennedy defended his actions vigorously during the hearing, arguing that changes were necessary to fix a “broken system” and restore trust in health agencies. He denied being anti-vaccine, instead positioning himself as pro-science and advocating for more research into vaccine risks.
The White House has backed Kennedy’s decisions, and allies like Vice President JD Vance and former strategist Steve Bannon have publicly supported him, framing the hearing as an attack on Trump’s administration. Internal polling suggests Kennedy remains popular among certain segments, bolstering his position.
Looking ahead, the fallout from this hearing could impact future HHS nominations and the administration’s health policies. While Trump’s support seems unwavering for now, the growing discontent within the Republican party may lead to further challenges for Kennedy’s agenda.
In summary, the event highlights the deepening divisions within the GOP over health policy and the strong alliance between Trump and Kennedy, despite widespread concerns about the direction of U.S. public health under Kennedy’s leadership.